Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

94.76
Delayed Data
As of Feb 24
 -0.94 / -0.98%
Today’s Change
81.12
Today|||52-Week Range
121.75
+1.13%
Year-to-Date
Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease
Feb 22 / MotleyFool.com - Paid Partner Content
Are Edwards Lifesciences Best Days Behind It?
Feb 21 / MotleyFool.com - Paid Partner Content
Baron Opportunity Fund Comments on Edwards
Feb 21 / GuruFocus News - Paid Partner Content
Why Edwards Lifesciences Could Bounce Back
Feb 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close95.70
Today’s open94.68
Day’s range94.12 - 95.02
Volume1,762,168
Average volume (3 months)2,607,306
Market cap$20.1B
Dividend yield--
Data as of 4:01pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+16.00%
Earnings growth (this year)+17.58%
Earnings growth (next 5 years)+15.90%
Revenue growth (last year)+18.85%
P/E ratio37.5
Price/Sales6.89
Price/Book7.66

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC-0.09-0.29%
ISRGIntuitive Surgical+1.51+0.21%
STESTERIS plc+0.84+1.21%
HRCHill-Rom Holdings In...+1.25+1.91%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateApril 25, 2017
EPS forecast (this quarter)$0.82
Annual revenue (last year)$3.0B
Annual profit (last year)$569.5M
Net profit margin19.22%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts


Search for Jobs